Independent reporting on GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound: how they work, side effects, muscle loss, cost, and what the trials really show.
Last updated 18 June 2026. Educational content only, not medical advice. Retatrutide is an investigational drug that is not FDA-approved.…
Last updated June 2026. Educational content, not medical advice. Peptides vary widely in legal status, mechanism, and risk. Talk to…
Recent findings suggest that GLP-1 receptor agonists, commonly used for weight loss, may dampen impulsivity and aggression, two key drivers…
Last updated 18 June 2026. Educational content, not medical advice. Prescription peptides require a licensed clinician. Research peptides are not…
Last updated 18 June 2026. Educational content, not medical advice. Retatrutide is not FDA-approved and remains investigational. Talk to a…
Last updated 18 June 2026. Educational content, not medical advice. Retatrutide is an investigational drug not approved by the FDA.…
Last updated 18 June 2026. Educational content, not medical advice. Retatrutide is an investigational drug that has not received FDA…
Last updated 18 June 2026. Educational content, not medical advice. The weight-loss “peptides” people search for are prescription GLP-1 drugs,…
Last updated 18 June 2026. Educational content, not medical advice. GLP-1 receptor agonists are prescription medications in the United States.…
Quick answer: Mounjaro, Ozempic, Wegovy, and Zepbound are four brand-name injectable medications built on just two molecules. Ozempic and Wegovy…
Last updated 18 June 2026. Educational content, not medical advice. Most peptides that generate weight-loss results are prescription drugs or…
Last updated 13 July 2026. Educational content only, not medical advice. Compounded tirzepatide is subject to significant regulatory restrictions in…